This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Bionomics Inc.. Active years: 2006-2009.
Company Filing History:
Years Active: 2006-2009
Title: David Frederick Callen: Innovator in Genetic Mapping
Introduction
David Frederick Callen is a notable inventor based in Malvern, Australia. He has made significant contributions to the field of genetics, particularly in the mapping of nucleic acid molecules. With a total of 2 patents to his name, Callen's work has implications for understanding genetic structures and their functions.
Latest Patents
Among his latest patents, Callen has developed the Gene BNO1 mapping to chromosome 16q24.3. This patent describes an isolated nucleic acid molecule that maps to chromosome 16q24.3 and comprises the nucleotide sequence set forth in SEQ ID Numbers: 1 or 3. Another patent focuses on the same gene, further emphasizing its importance in genetic research.
Career Highlights
Callen is associated with Bionomics Inc., a company that specializes in biotechnology and drug development. His work at Bionomics has allowed him to explore innovative solutions in the field of genetics. His research has contributed to advancements in understanding genetic disorders and potential therapeutic approaches.
Collaborations
Throughout his career, Callen has collaborated with notable colleagues such as Jason Powell and Gabriel Kremmidiotis. These partnerships have fostered a collaborative environment that enhances the research and development of genetic technologies.
Conclusion
David Frederick Callen's contributions to genetic mapping and his innovative patents highlight his role as a significant figure in the field of biotechnology. His work continues to pave the way for advancements in genetic research and therapeutic applications.